Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 6, 2009

View Archived Issues

The nAChR agonist WYE-103914 demonstrates efficacy in rodent cognition models

GF-015535-00 shows safety and potent sedative/hypnotic effects in vivo

SCY-635 shows synergistic antiviral activity in combination with anti-HCV agents in vitro

Lactin-V reduces recurrent urinary tract infection in phase II study

Significant weight loss, diabetes onset delay with liraglutide in obese subjects

Study in over 4,000 infants reveals immunogenicity of Hib-MenCY-TT vaccine

Germany approves CureVac's CV-9103 prostate cancer vaccine for phase IIa trial

FDA grants orphan drug designation to TNFerade

Aerovance completes patient enrollment in phase IIb Aerovant trial in asthma

Enobia Pharma initiates phase II trial of ENB-0040 in hypophosphatasia

Arpida confirms definitive agreement for intended merger with Evolva

Comparable immunogenicity of VRC DNA and rAD5 AIDS vaccines reported in healthy adults

Clinical evaluation of HIV antigen lipopeptide vaccines disclosed at AIDS Vaccine 2009

Amgen reports overall survival results for Vectibix in metastatic colorectal cancer

Acceleron initiates first-in-human study of ACE-041 in cancer patients

Aeolus' AEOL-10150 protects lungs against chlorine gas exposure in animal studies

Daiichi Sankyo launches new phase III trial of CS-8958 for flu prevention

FDA approves protocol amendment to SPA for phase III Lucanix study in NSCLC

Glenmark synthesizes novel TRPV3 receptor antagonists as analgesic agents

Flamel Technologies enters licensing agreement with Pfizer

New 11beta-HSD1 inhibitors claimed by sanofi-aventis for the treatment of type 2 diabetes

Banyu describes novel RSK1 inhibitors as oncolytics

Novel PD agent Lu 02-750 enters Lundbeck's development pipeline

Merck & Co. and Schering-Plough have completed their merger

Agennix acquires GPC Biotech

Novartis' influenza A(H1N1) vaccine Celtura approved in Germany

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...